Division of Maternal-Fetal Medicine, Obstetrics and Gynecology, Harvard Medical School, Brigham and Women's Hospital, 75 Francis St, Boston, MA, USA.
Hum Genet. 2020 Sep;139(9):1141-1148. doi: 10.1007/s00439-019-02061-1. Epub 2019 Sep 25.
Noninvasive prenatal testing has undergone rapid advances in the last few years. Although researchers have long known about circulating pregnancy-based cell-free fragments of DNA in maternal plasma, it was the introduction of massively parallel sequencing that allowed noninvasive prenatal testing to become a widely used clinical test. This review will begin with an in-depth analysis of the use of noninvasive prenatal testing for aneuploidy, including common causes for inaccurate and/or discordant results. It will also review the ongoing expansion of noninvasive prenatal testing to include copy number variants and select single-gene disorders. Finally, integrated throughout the review is a comparison of noninvasive prenatal testing to more traditional screening methods along with some medical and ethical implications of the widespread use of this new technology.
在过去的几年中,非侵入性产前检测取得了快速发展。尽管研究人员早就知道母体血浆中存在循环妊娠的游离 DNA 片段,但正是大规模平行测序的引入,使得非侵入性产前检测成为一种广泛应用的临床检测手段。本综述将首先深入分析非侵入性产前检测在非整倍体检测中的应用,包括导致检测结果不准确和/或不一致的常见原因。它还将回顾非侵入性产前检测在包括拷贝数变异和某些单基因疾病检测中的扩展。最后,本综述将比较非侵入性产前检测与更传统的筛查方法,并探讨这种新技术广泛应用的一些医学和伦理影响。